Global Digital Diabetes Management Market

Digital Diabetes Management Comprehensive Study by Type (Devices, Digital Diabetes Apps, Data Management Software and Platforms), Device Type (Wearable Devices, Handheld Devices), End User (Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, Academic & Research Institutes) Players and Region - Global Market Outlook to 2028

Digital Diabetes Management Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Digital Diabetes Management is expected to grow significantly in the forecasted period with the rising prevalence of diabetes and the growing adoption of the digital platform for diabetes. The rising incidence of type I and type II diabetes combined with high obese population is propelling the market for digital diabetes market.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledRoche Diagnostics (Switzerland), Medtronic (Ireland), Glooko Inc. (United States), B. Braun (Germany), Dexcom (United States), Abbott Laboratories (United States), Insulet Corporation (United States), Tandem Diabetes Care (United States), Ascensia Diabetes Care (Switzerland) and Lifescan (United States)


This growth is primarily driven by Growing Demand for Technologically Advanced Solutions Such As Closed-Loop Systems, High Adoption of Connected Diabetes Management Devices and Apps, Rising Awareness on Self-Diabetes Management, Favorable Reimbursement Policies and Increased Acceptance of Digital Diabetes Solutions from Payers.

Globally, a noticeable market trend is evident Growing Demand for Hybrid Closed-Loop Systems/Artificial Pancreas Device Systems Major Players, such as Roche Diagnostics (Switzerland), Medtronic (Ireland), Glooko Inc. (United States), B. Braun (Germany), Dexcom (United States), Abbott Laboratories (United States), Insulet Corporation (United States), Tandem Diabetes Care (United States), Ascensia Diabetes Care (Switzerland) and Lifescan (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In 2018, Medtronic plc acquired Neutrino Health Ltd. (Israel). This acquisition strengthened Metronic’s CGM and industry-leading hybrid closed-loop systems portfolio in the digital diabetes management market. and In 2018, Roche Diagnostics signed a partnership with Wellthy Therapeutics Private Limited (India) that offers an artificial intelligence-based digital diabetes coaching solution for users of the Accu-Chek Active system.

Influencing Trend:
Growing Demand for Hybrid Closed-Loop Systems/Artificial Pancreas Device Systems and Increasing Demand for Flash Glucose Monitoring (FGM) Systems

Market Growth Drivers:
Growing Demand for Technologically Advanced Solutions Such As Closed-Loop Systems, High Adoption of Connected Diabetes Management Devices and Apps, Rising Awareness on Self-Diabetes Management, Favorable Reimbursement Policies and Increased Acceptance of Digital Diabetes Solutions from Payers

Challenges:
Low Penetration in Developing Economies and Lack of Data Security

Restraints:
Lack of Awareness toward Healthcare-Associated Applications and Cost Sensitivity and Limited Infrastructure For Management

Opportunities:
Increasing Demand for Remote Monitoring & Penetration of Smartphone-Connected Handheld Devices, Rising Global Adoption of Remote Online Coaching Services among Diabetes Patients and Government Initiatives to Promote Digital Health in the Region

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Digital Diabetes Management Market
- Analysis about New Entrants in Digital Diabetes Management Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Digital Diabetes Management Study Sheds Light on
— The Digital Diabetes Management Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Digital Diabetes Management industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Digital Diabetes Management industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Devices
  • Digital Diabetes Apps
  • Data Management Software and Platforms
By Device Type
  • Wearable Devices
  • Handheld Devices

By End User
  • Self/Home Healthcare
  • Hospitals & Specialty Diabetes Clinics
  • Academic & Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Technologically Advanced Solutions Such As Closed-Loop Systems
      • 3.2.2. High Adoption of Connected Diabetes Management Devices and Apps
      • 3.2.3. Rising Awareness on Self-Diabetes Management
      • 3.2.4. Favorable Reimbursement Policies
      • 3.2.5. Increased Acceptance of Digital Diabetes Solutions from Payers
    • 3.3. Market Challenges
      • 3.3.1. Low Penetration in Developing Economies
      • 3.3.2. Lack of Data Security
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for Hybrid Closed-Loop Systems/Artificial Pancreas Device Systems
      • 3.4.2. Increasing Demand for Flash Glucose Monitoring (FGM) Systems
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Digital Diabetes Management, by Type, Device Type, End User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Digital Diabetes Management (Value)
      • 5.2.1. Global Digital Diabetes Management by: Type (Value)
        • 5.2.1.1. Devices
        • 5.2.1.2. Digital Diabetes Apps
        • 5.2.1.3. Data Management Software and Platforms
      • 5.2.2. Global Digital Diabetes Management by: Device Type (Value)
        • 5.2.2.1. Wearable Devices
        • 5.2.2.2. Handheld Devices
      • 5.2.3. Global Digital Diabetes Management by: End User (Value)
        • 5.2.3.1. Self/Home Healthcare
        • 5.2.3.2. Hospitals & Specialty Diabetes Clinics
        • 5.2.3.3. Academic & Research Institutes
      • 5.2.4. Global Digital Diabetes Management Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Digital Diabetes Management (Price)
      • 5.3.1. Global Digital Diabetes Management by: Type (Price)
  • 6. Digital Diabetes Management: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Diagnostics (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Glooko Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Dexcom (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Abbott Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Insulet Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Tandem Diabetes Care (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Ascensia Diabetes Care (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Lifescan (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Digital Diabetes Management Sale, by Type, Device Type, End User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Digital Diabetes Management (Value)
      • 7.2.1. Global Digital Diabetes Management by: Type (Value)
        • 7.2.1.1. Devices
        • 7.2.1.2. Digital Diabetes Apps
        • 7.2.1.3. Data Management Software and Platforms
      • 7.2.2. Global Digital Diabetes Management by: Device Type (Value)
        • 7.2.2.1. Wearable Devices
        • 7.2.2.2. Handheld Devices
      • 7.2.3. Global Digital Diabetes Management by: End User (Value)
        • 7.2.3.1. Self/Home Healthcare
        • 7.2.3.2. Hospitals & Specialty Diabetes Clinics
        • 7.2.3.3. Academic & Research Institutes
      • 7.2.4. Global Digital Diabetes Management Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Digital Diabetes Management (Price)
      • 7.3.1. Global Digital Diabetes Management by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Digital Diabetes Management: by Type(USD Million)
  • Table 2. Digital Diabetes Management Devices , by Region USD Million (2017-2022)
  • Table 3. Digital Diabetes Management Digital Diabetes Apps , by Region USD Million (2017-2022)
  • Table 4. Digital Diabetes Management Data Management Software and Platforms , by Region USD Million (2017-2022)
  • Table 5. Digital Diabetes Management: by Device Type(USD Million)
  • Table 6. Digital Diabetes Management Wearable Devices , by Region USD Million (2017-2022)
  • Table 7. Digital Diabetes Management Handheld Devices , by Region USD Million (2017-2022)
  • Table 8. Digital Diabetes Management: by End User(USD Million)
  • Table 9. Digital Diabetes Management Self/Home Healthcare , by Region USD Million (2017-2022)
  • Table 10. Digital Diabetes Management Hospitals & Specialty Diabetes Clinics , by Region USD Million (2017-2022)
  • Table 11. Digital Diabetes Management Academic & Research Institutes , by Region USD Million (2017-2022)
  • Table 12. South America Digital Diabetes Management, by Country USD Million (2017-2022)
  • Table 13. South America Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 14. South America Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 15. South America Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 16. Brazil Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 17. Brazil Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 18. Brazil Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 19. Argentina Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 20. Argentina Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 21. Argentina Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 22. Rest of South America Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 23. Rest of South America Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 24. Rest of South America Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 25. Asia Pacific Digital Diabetes Management, by Country USD Million (2017-2022)
  • Table 26. Asia Pacific Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 27. Asia Pacific Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 28. Asia Pacific Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 29. China Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 30. China Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 31. China Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 32. Japan Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 33. Japan Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 34. Japan Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 35. India Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 36. India Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 37. India Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 38. South Korea Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 39. South Korea Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 40. South Korea Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 41. Taiwan Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 42. Taiwan Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 43. Taiwan Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 44. Australia Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 45. Australia Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 46. Australia Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 47. Rest of Asia-Pacific Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 48. Rest of Asia-Pacific Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 49. Rest of Asia-Pacific Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 50. Europe Digital Diabetes Management, by Country USD Million (2017-2022)
  • Table 51. Europe Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 52. Europe Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 53. Europe Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 54. Germany Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 55. Germany Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 56. Germany Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 57. France Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 58. France Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 59. France Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 60. Italy Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 61. Italy Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 62. Italy Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 63. United Kingdom Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 64. United Kingdom Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 65. United Kingdom Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 66. Netherlands Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 67. Netherlands Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 68. Netherlands Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 69. Rest of Europe Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 70. Rest of Europe Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 71. Rest of Europe Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 72. MEA Digital Diabetes Management, by Country USD Million (2017-2022)
  • Table 73. MEA Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 74. MEA Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 75. MEA Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 76. Middle East Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 77. Middle East Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 78. Middle East Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 79. Africa Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 80. Africa Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 81. Africa Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 82. North America Digital Diabetes Management, by Country USD Million (2017-2022)
  • Table 83. North America Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 84. North America Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 85. North America Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 86. United States Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 87. United States Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 88. United States Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 89. Canada Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 90. Canada Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 91. Canada Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 92. Mexico Digital Diabetes Management, by Type USD Million (2017-2022)
  • Table 93. Mexico Digital Diabetes Management, by Device Type USD Million (2017-2022)
  • Table 94. Mexico Digital Diabetes Management, by End User USD Million (2017-2022)
  • Table 95. Digital Diabetes Management: by Type(USD/Units)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Digital Diabetes Management: by Type(USD Million)
  • Table 107. Digital Diabetes Management Devices , by Region USD Million (2023-2028)
  • Table 108. Digital Diabetes Management Digital Diabetes Apps , by Region USD Million (2023-2028)
  • Table 109. Digital Diabetes Management Data Management Software and Platforms , by Region USD Million (2023-2028)
  • Table 110. Digital Diabetes Management: by Device Type(USD Million)
  • Table 111. Digital Diabetes Management Wearable Devices , by Region USD Million (2023-2028)
  • Table 112. Digital Diabetes Management Handheld Devices , by Region USD Million (2023-2028)
  • Table 113. Digital Diabetes Management: by End User(USD Million)
  • Table 114. Digital Diabetes Management Self/Home Healthcare , by Region USD Million (2023-2028)
  • Table 115. Digital Diabetes Management Hospitals & Specialty Diabetes Clinics , by Region USD Million (2023-2028)
  • Table 116. Digital Diabetes Management Academic & Research Institutes , by Region USD Million (2023-2028)
  • Table 117. South America Digital Diabetes Management, by Country USD Million (2023-2028)
  • Table 118. South America Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 119. South America Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 120. South America Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 121. Brazil Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 122. Brazil Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 123. Brazil Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 124. Argentina Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 125. Argentina Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 126. Argentina Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 127. Rest of South America Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 128. Rest of South America Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 129. Rest of South America Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 130. Asia Pacific Digital Diabetes Management, by Country USD Million (2023-2028)
  • Table 131. Asia Pacific Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 132. Asia Pacific Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 133. Asia Pacific Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 134. China Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 135. China Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 136. China Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 137. Japan Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 138. Japan Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 139. Japan Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 140. India Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 141. India Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 142. India Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 143. South Korea Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 144. South Korea Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 145. South Korea Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 146. Taiwan Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 147. Taiwan Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 148. Taiwan Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 149. Australia Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 150. Australia Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 151. Australia Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 152. Rest of Asia-Pacific Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 153. Rest of Asia-Pacific Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 154. Rest of Asia-Pacific Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 155. Europe Digital Diabetes Management, by Country USD Million (2023-2028)
  • Table 156. Europe Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 157. Europe Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 158. Europe Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 159. Germany Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 160. Germany Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 161. Germany Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 162. France Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 163. France Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 164. France Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 165. Italy Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 166. Italy Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 167. Italy Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 168. United Kingdom Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 169. United Kingdom Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 170. United Kingdom Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 171. Netherlands Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 172. Netherlands Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 173. Netherlands Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 174. Rest of Europe Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 175. Rest of Europe Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 176. Rest of Europe Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 177. MEA Digital Diabetes Management, by Country USD Million (2023-2028)
  • Table 178. MEA Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 179. MEA Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 180. MEA Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 181. Middle East Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 182. Middle East Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 183. Middle East Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 184. Africa Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 185. Africa Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 186. Africa Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 187. North America Digital Diabetes Management, by Country USD Million (2023-2028)
  • Table 188. North America Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 189. North America Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 190. North America Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 191. United States Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 192. United States Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 193. United States Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 194. Canada Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 195. Canada Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 196. Canada Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 197. Mexico Digital Diabetes Management, by Type USD Million (2023-2028)
  • Table 198. Mexico Digital Diabetes Management, by Device Type USD Million (2023-2028)
  • Table 199. Mexico Digital Diabetes Management, by End User USD Million (2023-2028)
  • Table 200. Digital Diabetes Management: by Type(USD/Units)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Digital Diabetes Management: by Type USD Million (2017-2022)
  • Figure 5. Global Digital Diabetes Management: by Device Type USD Million (2017-2022)
  • Figure 6. Global Digital Diabetes Management: by End User USD Million (2017-2022)
  • Figure 7. South America Digital Diabetes Management Share (%), by Country
  • Figure 8. Asia Pacific Digital Diabetes Management Share (%), by Country
  • Figure 9. Europe Digital Diabetes Management Share (%), by Country
  • Figure 10. MEA Digital Diabetes Management Share (%), by Country
  • Figure 11. North America Digital Diabetes Management Share (%), by Country
  • Figure 12. Global Digital Diabetes Management: by Type USD/Units (2017-2022)
  • Figure 13. Global Digital Diabetes Management share by Players 2022 (%)
  • Figure 14. Global Digital Diabetes Management share by Players (Top 3) 2022(%)
  • Figure 15. Global Digital Diabetes Management share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Roche Diagnostics (Switzerland) Revenue: by Geography 2022
  • Figure 19. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 20. Medtronic (Ireland) Revenue: by Geography 2022
  • Figure 21. Glooko Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Glooko Inc. (United States) Revenue: by Geography 2022
  • Figure 23. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 24. B. Braun (Germany) Revenue: by Geography 2022
  • Figure 25. Dexcom (United States) Revenue, Net Income and Gross profit
  • Figure 26. Dexcom (United States) Revenue: by Geography 2022
  • Figure 27. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 28. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 29. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Insulet Corporation (United States) Revenue: by Geography 2022
  • Figure 31. Tandem Diabetes Care (United States) Revenue, Net Income and Gross profit
  • Figure 32. Tandem Diabetes Care (United States) Revenue: by Geography 2022
  • Figure 33. Ascensia Diabetes Care (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Ascensia Diabetes Care (Switzerland) Revenue: by Geography 2022
  • Figure 35. Lifescan (United States) Revenue, Net Income and Gross profit
  • Figure 36. Lifescan (United States) Revenue: by Geography 2022
  • Figure 37. Global Digital Diabetes Management: by Type USD Million (2023-2028)
  • Figure 38. Global Digital Diabetes Management: by Device Type USD Million (2023-2028)
  • Figure 39. Global Digital Diabetes Management: by End User USD Million (2023-2028)
  • Figure 40. South America Digital Diabetes Management Share (%), by Country
  • Figure 41. Asia Pacific Digital Diabetes Management Share (%), by Country
  • Figure 42. Europe Digital Diabetes Management Share (%), by Country
  • Figure 43. MEA Digital Diabetes Management Share (%), by Country
  • Figure 44. North America Digital Diabetes Management Share (%), by Country
  • Figure 45. Global Digital Diabetes Management: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Roche Diagnostics (Switzerland)
  • Medtronic (Ireland)
  • Glooko Inc. (United States)
  • B. Braun (Germany)
  • Dexcom (United States)
  • Abbott Laboratories (United States)
  • Insulet Corporation (United States)
  • Tandem Diabetes Care (United States)
  • Ascensia Diabetes Care (Switzerland)
  • Lifescan (United States)
Additional players considered in the study are as follows:
Tidepool (United States) , Agamatrix (United States) , Dariohealth (Israel)
Select User Access Type

Key Highlights of Report


Apr 2023 146 Pages 90 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Digital Diabetes Management Market Quantitative research analysis
Global Digital Diabetes Management Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Digital Diabetes Management market are Roche Diagnostics (Switzerland), Medtronic (Ireland), Glooko Inc. (United States), B. Braun (Germany), Dexcom (United States), Abbott Laboratories (United States), Insulet Corporation (United States), Tandem Diabetes Care (United States), Ascensia Diabetes Care (Switzerland) and Lifescan (United States), to name a few.
is dominating the Digital Diabetes Management Market.
"Low Penetration in Developing Economies " is seen as one of the major challenges by many Industry Players of Digital Diabetes Management Market
The Digital Diabetes Management market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Digital Diabetes Management market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Digital Diabetes Management Market Report?

Have a Query? Click Here

Other Related Reports

Cancer Cachexia Comprehensive Study by Type (Progestogens, Corticosteroids, Combination Therapies, Others), Application (Clinical, Screening, Research), Mechanism of Action (Appetite Stimulators, Wei...
$ 3650
Spironolactones Comprehensive Study by Application (Hospitals, Specialty Clinics, Others), Form (Liquid, Tablet), Dosage Types (Child Dosage (0-17), Adult Dosage (18-64), Senior Dosage (65 and older)...
$ 3350
Rosacea Drugs Comprehensive Study by Type (Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, Others), Mode of Administration (Topical, Orals), Dist...
$ 3350
Dermal Adhesives Comprehensive Study by Type (Synthetic, Natural), Application (Hospitals, Clinics), End Users (Hospitals, Clinics), Distribution Channel (Online {Company Websites, E-Commerce Website...
$ 3450
Skin Glue Comprehensive Study by Type (Synthetic, Natural), Application (Hospitals, Clinics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Players and Region - Glo...
$ 3500
Generic Drug Comprehensive Study by Type (Pure (Non-branded) Generics , Branded Generics , Super Generics), Application (Cardiovascular & Hypertension, Dermatology, Diabetes, Rheumatology, Oncology, ...
$ 3650